Related Experiment Video
Updated: Nov 19, 2025
09:12
Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
Published on: October 17, 2018
58.4K
Dynamic changes in monocytes subsets in COVID-19 patients
Shuang Qin1, Yujie Jiang1, Xin Wei2
1Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Human Immunology
|February 3, 2021
Summary
Critical COVID-19 patients show reduced monocyte counts and impaired antigen presentation, alongside increased pro-inflammatory monocytes. Monocyte HLA-DR expression may help predict severe COVID-19 cases.
Area of Science:
- Immunology
- Virology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) poses a global health threat.
- Understanding the immunological response in critical COVID-19 is crucial.
Purpose of the Study:
- Investigate monocyte immunological characteristics in critical COVID-19 patients.
- Determine the role of monocyte subsets in COVID-19 pathogenesis.
Main Methods:
- Flow cytometry used to analyze monocyte counts and immune status.
- Study included 32 COVID-19 patients and 18 healthy controls.
Main Results:
- Critical COVID-19 patients had decreased total and CD16- monocytes but increased CD16+ pro-inflammatory monocytes.
- Monocyte antigen presentation (HLA-DR) was suppressed, while inflammatory markers (CD38) were elevated.
- Elevated IL-6 correlated with CD16+ monocytes; IL-6 and IL-10 correlated negatively with HLA-DR.
Conclusions:
- Reduced monocyte HLA-DR expression may cause immunosuppression in critical COVID-19.
- Increased CD16+ monocytes might drive hyperinflammation.
- HLA-DR+ monocytes show potential as predictive biomarkers for severe COVID-19.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
3.6K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K
01:27Disorders of Leukocytes
1.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.5K